The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hunter William L since 2008.
The trader's CIK number is 1432062.
At the time of the last reporting, Hunter William L was the President and CEO of Angiotech Pharmaceuticals Inc. (stock ticker symbol ANPI).
Also see all insider trading activities at Angiotech Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | ANPI | 913,691 | $551,594 | 0 | $0 | 0 | $0 |
| 2008 | ANPI | 4,567,144 | $767,325 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-11-20 | ANPI | Buy | 15,600 | 1.39 | 21,684 |
| 2009-09-29 | ANPI | Buy | 49,500 | 1.90 | 93,951 |
| 2009-05-05 | ANPI | Buy | 157,738 | .56 | 87,702 |
| 2009-05-01 | ANPI | Buy | 444,670 | .58 | 257,908 |
| 2009-05-04 | ANPI | Buy | 32,143 | .60 | 19,285 |
| 2009-03-18 | ANPI | Buy | 30,500 | .40 | 12,291 |
| 2009-03-17 | ANPI | Buy | 53,000 | .35 | 18,550 |
| 2009-03-16 | ANPI | Buy | 40,848 | .32 | 12,867 |
| 2009-03-13 | ANPI | Buy | 89,692 | .30 | 27,356 |
| 2008-12-23 | ANPI | Buy | 33,000 | .19 | 6,237 |
| 2008-12-22 | ANPI | Buy | 567,595 | .16 | 89,112 |
| 2008-12-22 | ANPI | Buy | 156,933 | .16 | 25,109 |
| 2008-12-19 | ANPI | Buy | 901,513 | .17 | 154,158 |
| 2008-12-22 | ANPI | Buy | 12,472 | .15 | 1,895 |
| 2008-12-18 | ANPI | Buy | 223,631 | .17 | 37,122 |
| 2008-12-17 | ANPI | Buy | 169,761 | .16 | 27,840 |
| 2008-12-17 | ANPI | Buy | 202,250 | .15 | 31,146 |
| 2008-12-12 | ANPI | Buy | 263,241 | .17 | 43,434 |
| 2008-12-15 | ANPI | Buy | 1,396,748 | .17 | 240,240 |
| 2008-12-09 | ANPI | Buy | 375,000 | .17 | 65,249 |
| 2008-12-10 | ANPI | Buy | 102,000 | .17 | 17,748 |
| 2008-12-11 | ANPI | Buy | 163,000 | .17 | 28,035 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hunter William L (President and CEO of Angiotech Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.